| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Arthroplasty, Replacement, Hip | 29 | 2023 | 99 | 11.350 |
Why?
|
| Arthroplasty, Replacement, Knee | 26 | 2024 | 111 | 10.120 |
Why?
|
| Postoperative Complications | 21 | 2023 | 2591 | 3.500 |
Why?
|
| Rivers | 8 | 2025 | 21 | 2.710 |
Why?
|
| Acetabulum | 6 | 2019 | 21 | 2.450 |
Why?
|
| Hip Prosthesis | 8 | 2019 | 28 | 2.430 |
Why?
|
| Osteoarthritis, Hip | 3 | 2020 | 22 | 1.820 |
Why?
|
| Postoperative Period | 11 | 2020 | 318 | 1.600 |
Why?
|
| Osteoarthritis, Knee | 5 | 2024 | 71 | 1.470 |
Why?
|
| Patient Reported Outcome Measures | 4 | 2021 | 286 | 1.370 |
Why?
|
| Patient Readmission | 9 | 2019 | 413 | 1.370 |
Why?
|
| Ecosystem | 6 | 2023 | 394 | 1.310 |
Why?
|
| Pulmonary Embolism | 3 | 2023 | 235 | 1.300 |
Why?
|
| Knee Joint | 4 | 2019 | 166 | 1.260 |
Why?
|
| Fungi | 4 | 2017 | 67 | 1.200 |
Why?
|
| Hip Fractures | 3 | 2018 | 51 | 1.190 |
Why?
|
| Risk Factors | 19 | 2023 | 5960 | 1.170 |
Why?
|
| Risk Assessment | 7 | 2019 | 2480 | 1.170 |
Why?
|
| Length of Stay | 9 | 2023 | 833 | 1.150 |
Why?
|
| Aged | 35 | 2025 | 20964 | 1.040 |
Why?
|
| Nitrogen | 8 | 2025 | 79 | 1.020 |
Why?
|
| Pelvic Bones | 2 | 2017 | 45 | 0.990 |
Why?
|
| Patient Discharge | 6 | 2019 | 361 | 0.990 |
Why?
|
| Biodegradation, Environmental | 2 | 2016 | 18 | 0.970 |
Why?
|
| Joint Diseases | 3 | 2015 | 48 | 0.970 |
Why?
|
| Pain, Postoperative | 5 | 2024 | 277 | 0.960 |
Why?
|
| Reoperation | 7 | 2020 | 707 | 0.960 |
Why?
|
| Surgical Wound Infection | 3 | 2017 | 237 | 0.930 |
Why?
|
| Antibiotic Prophylaxis | 2 | 2017 | 84 | 0.930 |
Why?
|
| Phosphorus | 6 | 2025 | 119 | 0.930 |
Why?
|
| Metabolic Syndrome | 2 | 2016 | 127 | 0.900 |
Why?
|
| Body Mass Index | 3 | 2018 | 815 | 0.900 |
Why?
|
| Odds Ratio | 8 | 2017 | 713 | 0.880 |
Why?
|
| Quality Improvement | 9 | 2019 | 502 | 0.870 |
Why?
|
| Hip Joint | 3 | 2019 | 56 | 0.860 |
Why?
|
| Range of Motion, Articular | 3 | 2019 | 180 | 0.850 |
Why?
|
| Bacteria | 3 | 2017 | 517 | 0.830 |
Why?
|
| Carbon | 5 | 2023 | 97 | 0.830 |
Why?
|
| Plant Leaves | 6 | 2025 | 88 | 0.830 |
Why?
|
| Prosthesis Failure | 4 | 2010 | 125 | 0.820 |
Why?
|
| Staphylococcal Infections | 2 | 2017 | 289 | 0.800 |
Why?
|
| Male | 40 | 2025 | 45870 | 0.790 |
Why?
|
| Humans | 60 | 2025 | 96127 | 0.760 |
Why?
|
| Orthopedics | 2 | 2015 | 138 | 0.760 |
Why?
|
| Middle Aged | 30 | 2025 | 28363 | 0.750 |
Why?
|
| Knee Prosthesis | 2 | 2019 | 24 | 0.740 |
Why?
|
| Female | 37 | 2025 | 50063 | 0.720 |
Why?
|
| Intraoperative Care | 2 | 2019 | 89 | 0.710 |
Why?
|
| United States | 15 | 2025 | 7767 | 0.700 |
Why?
|
| Databases, Factual | 7 | 2019 | 1010 | 0.690 |
Why?
|
| Anti-Bacterial Agents | 2 | 2017 | 847 | 0.660 |
Why?
|
| Prosthesis Design | 3 | 2019 | 310 | 0.650 |
Why?
|
| Obesity | 3 | 2016 | 1034 | 0.650 |
Why?
|
| Elective Surgical Procedures | 3 | 2020 | 162 | 0.640 |
Why?
|
| Blood Transfusion | 3 | 2019 | 182 | 0.620 |
Why?
|
| Oxygen Consumption | 2 | 2017 | 257 | 0.610 |
Why?
|
| Propensity Score | 5 | 2017 | 180 | 0.600 |
Why?
|
| Time Factors | 7 | 2025 | 5585 | 0.600 |
Why?
|
| Anatomic Landmarks | 1 | 2019 | 31 | 0.600 |
Why?
|
| Treatment Outcome | 14 | 2025 | 9173 | 0.590 |
Why?
|
| Femoral Neck Fractures | 1 | 2018 | 10 | 0.580 |
Why?
|
| Walking | 1 | 2019 | 106 | 0.580 |
Why?
|
| Arthroplasty, Replacement | 1 | 2018 | 38 | 0.570 |
Why?
|
| Fracture Fixation | 1 | 2018 | 35 | 0.570 |
Why?
|
| Atrial Fibrillation | 1 | 2023 | 392 | 0.570 |
Why?
|
| Retrospective Studies | 12 | 2025 | 10286 | 0.570 |
Why?
|
| Femur | 2 | 2015 | 108 | 0.560 |
Why?
|
| Venous Thromboembolism | 2 | 2018 | 171 | 0.550 |
Why?
|
| International Normalized Ratio | 1 | 2018 | 38 | 0.550 |
Why?
|
| Bupivacaine | 3 | 2016 | 48 | 0.530 |
Why?
|
| Aged, 80 and over | 11 | 2025 | 7232 | 0.530 |
Why?
|
| Warfarin | 1 | 2018 | 107 | 0.520 |
Why?
|
| Invertebrates | 4 | 2025 | 36 | 0.520 |
Why?
|
| Osteonecrosis | 1 | 2017 | 21 | 0.520 |
Why?
|
| Inpatients | 2 | 2019 | 347 | 0.510 |
Why?
|
| Necrosis | 1 | 2017 | 210 | 0.500 |
Why?
|
| Cohort Studies | 6 | 2019 | 3107 | 0.490 |
Why?
|
| Radiostereometric Analysis | 1 | 2015 | 2 | 0.480 |
Why?
|
| Smoking | 2 | 2017 | 653 | 0.480 |
Why?
|
| Hospitals, High-Volume | 1 | 2016 | 42 | 0.470 |
Why?
|
| Outpatients | 1 | 2016 | 105 | 0.470 |
Why?
|
| Arthroplasty | 2 | 2020 | 37 | 0.470 |
Why?
|
| Nerve Block | 2 | 2016 | 52 | 0.470 |
Why?
|
| Comorbidity | 5 | 2019 | 1011 | 0.470 |
Why?
|
| Fractures, Bone | 1 | 2017 | 155 | 0.450 |
Why?
|
| Models, Statistical | 1 | 2018 | 594 | 0.450 |
Why?
|
| Femoral Vein | 1 | 2014 | 42 | 0.440 |
Why?
|
| Fluoroscopy | 3 | 2019 | 138 | 0.430 |
Why?
|
| Anticoagulants | 1 | 2018 | 463 | 0.430 |
Why?
|
| Blood Flow Velocity | 1 | 2014 | 202 | 0.430 |
Why?
|
| Logistic Models | 5 | 2020 | 1268 | 0.430 |
Why?
|
| Postoperative Care | 2 | 2023 | 239 | 0.370 |
Why?
|
| Arthralgia | 1 | 2011 | 41 | 0.350 |
Why?
|
| Pain Management | 1 | 2013 | 179 | 0.350 |
Why?
|
| Foreign-Body Migration | 1 | 2010 | 34 | 0.330 |
Why?
|
| Femoral Artery | 1 | 2010 | 91 | 0.320 |
Why?
|
| Pain Measurement | 4 | 2024 | 378 | 0.320 |
Why?
|
| Hand Injuries | 1 | 2010 | 16 | 0.320 |
Why?
|
| Bone Screws | 1 | 2010 | 73 | 0.310 |
Why?
|
| Tendon Injuries | 1 | 2010 | 39 | 0.310 |
Why?
|
| Lacerations | 1 | 2010 | 30 | 0.310 |
Why?
|
| Orthopedic Procedures | 3 | 2020 | 152 | 0.310 |
Why?
|
| Medicare | 3 | 2019 | 458 | 0.300 |
Why?
|
| Education, Medical, Graduate | 1 | 2013 | 436 | 0.300 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2015 | 1323 | 0.300 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2014 | 595 | 0.300 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2019 | 2781 | 0.290 |
Why?
|
| Biomass | 3 | 2017 | 43 | 0.280 |
Why?
|
| Imaging, Three-Dimensional | 3 | 2019 | 630 | 0.280 |
Why?
|
| Students, Medical | 1 | 2013 | 455 | 0.270 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2014 | 1230 | 0.240 |
Why?
|
| Polyethylene | 1 | 2005 | 7 | 0.240 |
Why?
|
| Temperature | 2 | 2017 | 426 | 0.240 |
Why?
|
| Prisons | 1 | 2025 | 15 | 0.230 |
Why?
|
| Forests | 1 | 2025 | 29 | 0.230 |
Why?
|
| Organizational Policy | 1 | 2025 | 58 | 0.230 |
Why?
|
| Glaucoma Drainage Implants | 1 | 2025 | 11 | 0.220 |
Why?
|
| Intraocular Pressure | 1 | 2025 | 63 | 0.220 |
Why?
|
| Glaucoma | 1 | 2025 | 36 | 0.220 |
Why?
|
| Regression Analysis | 2 | 2016 | 599 | 0.210 |
Why?
|
| Hyperalgesia | 1 | 2024 | 22 | 0.210 |
Why?
|
| Neuralgia | 1 | 2024 | 33 | 0.210 |
Why?
|
| Research | 1 | 2025 | 265 | 0.210 |
Why?
|
| Pain Threshold | 1 | 2024 | 63 | 0.210 |
Why?
|
| Suture Techniques | 1 | 2025 | 143 | 0.210 |
Why?
|
| Visual Acuity | 1 | 2025 | 209 | 0.210 |
Why?
|
| Patient Satisfaction | 3 | 2019 | 514 | 0.210 |
Why?
|
| Internship and Residency | 1 | 2013 | 1134 | 0.210 |
Why?
|
| Phantoms, Imaging | 2 | 2017 | 491 | 0.210 |
Why?
|
| Lignin | 1 | 2023 | 6 | 0.200 |
Why?
|
| Internet | 1 | 2025 | 339 | 0.200 |
Why?
|
| Multivariate Analysis | 2 | 2016 | 1010 | 0.190 |
Why?
|
| Registries | 2 | 2019 | 986 | 0.190 |
Why?
|
| Hemoglobins | 2 | 2023 | 196 | 0.190 |
Why?
|
| Predictive Value of Tests | 2 | 2018 | 1807 | 0.190 |
Why?
|
| Antifibrinolytic Agents | 1 | 2023 | 44 | 0.190 |
Why?
|
| Tranexamic Acid | 1 | 2023 | 43 | 0.190 |
Why?
|
| Stents | 1 | 2025 | 425 | 0.180 |
Why?
|
| Prevalence | 2 | 2017 | 1349 | 0.180 |
Why?
|
| Societies, Medical | 2 | 2016 | 644 | 0.180 |
Why?
|
| Animals | 9 | 2025 | 28945 | 0.180 |
Why?
|
| Anesthetics, Local | 2 | 2016 | 84 | 0.180 |
Why?
|
| Health Status | 2 | 2021 | 386 | 0.170 |
Why?
|
| Reproducibility of Results | 5 | 2021 | 2883 | 0.160 |
Why?
|
| Urinalysis | 1 | 2020 | 34 | 0.160 |
Why?
|
| Agriculture | 1 | 2020 | 44 | 0.160 |
Why?
|
| Adult | 10 | 2023 | 28718 | 0.160 |
Why?
|
| France | 1 | 2019 | 54 | 0.150 |
Why?
|
| Quality Indicators, Health Care | 1 | 2020 | 155 | 0.150 |
Why?
|
| Psychometrics | 2 | 2021 | 340 | 0.150 |
Why?
|
| Weight-Bearing | 1 | 2019 | 73 | 0.150 |
Why?
|
| Physical Therapy Modalities | 1 | 2019 | 93 | 0.150 |
Why?
|
| Single-Blind Method | 1 | 2019 | 162 | 0.140 |
Why?
|
| Operative Time | 1 | 2019 | 167 | 0.140 |
Why?
|
| Reference Standards | 1 | 2018 | 150 | 0.140 |
Why?
|
| Pain | 1 | 2021 | 426 | 0.140 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2019 | 118 | 0.140 |
Why?
|
| Hospitals | 1 | 2020 | 329 | 0.140 |
Why?
|
| Blood Coagulation | 1 | 2018 | 90 | 0.140 |
Why?
|
| Joint Instability | 1 | 2018 | 99 | 0.130 |
Why?
|
| Rotation | 1 | 2017 | 94 | 0.130 |
Why?
|
| Posture | 1 | 2017 | 130 | 0.130 |
Why?
|
| Platelet Transfusion | 1 | 2017 | 16 | 0.130 |
Why?
|
| Amides | 1 | 2016 | 56 | 0.130 |
Why?
|
| Time-to-Treatment | 1 | 2018 | 140 | 0.130 |
Why?
|
| Awards and Prizes | 1 | 2017 | 37 | 0.130 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2017 | 85 | 0.120 |
Why?
|
| Venous Thrombosis | 1 | 2019 | 257 | 0.120 |
Why?
|
| Electronic Health Records | 1 | 2020 | 372 | 0.120 |
Why?
|
| Juvenile Delinquency | 1 | 1996 | 29 | 0.120 |
Why?
|
| Bone Malalignment | 1 | 2015 | 6 | 0.120 |
Why?
|
| Chicago | 2 | 2017 | 1503 | 0.120 |
Why?
|
| North Carolina | 1 | 2015 | 56 | 0.120 |
Why?
|
| Heart Arrest | 1 | 2019 | 312 | 0.120 |
Why?
|
| Myocardial Infarction | 1 | 2019 | 429 | 0.120 |
Why?
|
| Adolescent | 5 | 2023 | 9896 | 0.120 |
Why?
|
| Carbon Sequestration | 1 | 2015 | 3 | 0.110 |
Why?
|
| Peptostreptococcus | 1 | 2015 | 3 | 0.110 |
Why?
|
| Historically Controlled Study | 1 | 2015 | 6 | 0.110 |
Why?
|
| Water Pollution | 1 | 2015 | 10 | 0.110 |
Why?
|
| Reimbursement, Incentive | 1 | 2015 | 39 | 0.110 |
Why?
|
| Patient Selection | 1 | 2018 | 709 | 0.110 |
Why?
|
| Fracture Fixation, Intramedullary | 1 | 2014 | 17 | 0.110 |
Why?
|
| Food Chain | 1 | 2015 | 65 | 0.110 |
Why?
|
| Femoral Fractures | 1 | 2014 | 34 | 0.110 |
Why?
|
| Respiratory Tract Diseases | 1 | 2014 | 47 | 0.110 |
Why?
|
| Clinical Protocols | 1 | 2015 | 162 | 0.110 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 1996 | 504 | 0.110 |
Why?
|
| Probability | 1 | 2015 | 365 | 0.110 |
Why?
|
| Evidence-Based Practice | 1 | 2014 | 51 | 0.110 |
Why?
|
| Likelihood Functions | 1 | 2014 | 257 | 0.100 |
Why?
|
| Eye Movements | 1 | 2014 | 119 | 0.100 |
Why?
|
| Minority Groups | 1 | 2015 | 154 | 0.100 |
Why?
|
| Analgesia, Patient-Controlled | 1 | 2013 | 16 | 0.100 |
Why?
|
| Colonography, Computed Tomographic | 1 | 2014 | 83 | 0.100 |
Why?
|
| Double-Blind Method | 3 | 2016 | 1791 | 0.100 |
Why?
|
| Injections, Intra-Articular | 1 | 2013 | 33 | 0.100 |
Why?
|
| Drug Administration Schedule | 1 | 2015 | 873 | 0.100 |
Why?
|
| Colonic Polyps | 1 | 2014 | 137 | 0.100 |
Why?
|
| Residence Characteristics | 1 | 2015 | 213 | 0.100 |
Why?
|
| Observer Variation | 1 | 2014 | 626 | 0.100 |
Why?
|
| Surveys and Questionnaires | 3 | 2020 | 2860 | 0.100 |
Why?
|
| Transgender Persons | 1 | 2015 | 132 | 0.100 |
Why?
|
| Analysis of Variance | 1 | 2014 | 910 | 0.090 |
Why?
|
| Preoperative Care | 1 | 2015 | 418 | 0.090 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2014 | 287 | 0.090 |
Why?
|
| Analgesics | 1 | 2013 | 132 | 0.090 |
Why?
|
| Ultrasonography | 1 | 2014 | 744 | 0.090 |
Why?
|
| Smoking Cessation | 1 | 2015 | 272 | 0.090 |
Why?
|
| Stress, Psychological | 1 | 2015 | 345 | 0.090 |
Why?
|
| Premedication | 1 | 2011 | 58 | 0.090 |
Why?
|
| Incidence | 1 | 2016 | 1715 | 0.090 |
Why?
|
| Educational Measurement | 1 | 2013 | 246 | 0.090 |
Why?
|
| Software | 1 | 2015 | 698 | 0.090 |
Why?
|
| Cross-Sectional Studies | 3 | 2025 | 1874 | 0.090 |
Why?
|
| Computer Simulation | 1 | 2015 | 1158 | 0.090 |
Why?
|
| Young Adult | 3 | 2021 | 7025 | 0.090 |
Why?
|
| Visual Perception | 1 | 2014 | 339 | 0.080 |
Why?
|
| Models, Biological | 2 | 2015 | 1815 | 0.080 |
Why?
|
| Surgeons | 1 | 2015 | 298 | 0.080 |
Why?
|
| Foot | 1 | 2010 | 59 | 0.080 |
Why?
|
| Hospitalization | 1 | 2016 | 943 | 0.080 |
Why?
|
| Arthritis | 1 | 2010 | 53 | 0.080 |
Why?
|
| Osteoblasts | 2 | 2008 | 98 | 0.080 |
Why?
|
| Nausea | 1 | 2011 | 182 | 0.080 |
Why?
|
| Stroke | 1 | 2019 | 1087 | 0.080 |
Why?
|
| Thromboembolism | 1 | 2010 | 128 | 0.080 |
Why?
|
| Tensile Strength | 1 | 2010 | 86 | 0.080 |
Why?
|
| Cadaver | 1 | 2010 | 204 | 0.080 |
Why?
|
| Ischemia | 1 | 2010 | 257 | 0.070 |
Why?
|
| Clinical Competence | 1 | 2014 | 854 | 0.070 |
Why?
|
| Kell Blood-Group System | 1 | 2007 | 3 | 0.070 |
Why?
|
| Follow-Up Studies | 2 | 2025 | 3927 | 0.070 |
Why?
|
| Biomechanical Phenomena | 1 | 2010 | 506 | 0.070 |
Why?
|
| Bone Development | 1 | 2008 | 38 | 0.070 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2007 | 38 | 0.070 |
Why?
|
| Hematologic Diseases | 1 | 2007 | 79 | 0.070 |
Why?
|
| Cardiovascular Diseases | 1 | 2014 | 777 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2011 | 1973 | 0.070 |
Why?
|
| Movement | 1 | 2010 | 325 | 0.070 |
Why?
|
| Isoantibodies | 1 | 2007 | 127 | 0.060 |
Why?
|
| Bone and Bones | 1 | 2008 | 280 | 0.060 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2007 | 132 | 0.060 |
Why?
|
| Hip Dislocation | 1 | 2005 | 8 | 0.060 |
Why?
|
| Ilium | 1 | 2005 | 31 | 0.060 |
Why?
|
| Materials Testing | 1 | 2005 | 94 | 0.060 |
Why?
|
| Stem Cells | 1 | 2008 | 394 | 0.060 |
Why?
|
| Bone Transplantation | 1 | 2005 | 79 | 0.060 |
Why?
|
| Longitudinal Studies | 2 | 2021 | 1175 | 0.060 |
Why?
|
| Spinal Diseases | 1 | 2005 | 99 | 0.050 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2008 | 677 | 0.050 |
Why?
|
| Fresh Water | 1 | 2023 | 24 | 0.050 |
Why?
|
| Hemarthrosis | 1 | 2023 | 3 | 0.050 |
Why?
|
| Suction | 1 | 2023 | 38 | 0.050 |
Why?
|
| Administration, Intravenous | 1 | 2023 | 66 | 0.050 |
Why?
|
| Plants | 1 | 2023 | 127 | 0.050 |
Why?
|
| Blood Loss, Surgical | 1 | 2023 | 133 | 0.050 |
Why?
|
| Causality | 1 | 2021 | 84 | 0.040 |
Why?
|
| Radiography | 1 | 2019 | 826 | 0.030 |
Why?
|
| Alnus | 1 | 2017 | 2 | 0.030 |
Why?
|
| Academic Medical Centers | 1 | 2020 | 422 | 0.030 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2016 | 41 | 0.030 |
Why?
|
| Climate Change | 1 | 2017 | 62 | 0.030 |
Why?
|
| Social Adjustment | 1 | 1996 | 48 | 0.030 |
Why?
|
| Florida | 1 | 1996 | 63 | 0.030 |
Why?
|
| Prospective Studies | 2 | 2020 | 4671 | 0.030 |
Why?
|
| Prognosis | 1 | 2024 | 4033 | 0.030 |
Why?
|
| Ultrasonography, Interventional | 1 | 2016 | 125 | 0.030 |
Why?
|
| Sex Distribution | 1 | 1996 | 175 | 0.030 |
Why?
|
| Age Distribution | 1 | 1996 | 209 | 0.030 |
Why?
|
| Osteogenesis | 2 | 2008 | 277 | 0.030 |
Why?
|
| Rhododendron | 1 | 2015 | 1 | 0.030 |
Why?
|
| Liriodendron | 1 | 2015 | 1 | 0.030 |
Why?
|
| Acer | 1 | 2015 | 2 | 0.030 |
Why?
|
| San Francisco | 1 | 2015 | 26 | 0.030 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 2015 | 27 | 0.030 |
Why?
|
| Homosexuality, Female | 1 | 2015 | 17 | 0.030 |
Why?
|
| Triage | 1 | 1996 | 132 | 0.030 |
Why?
|
| Bisexuality | 1 | 2015 | 36 | 0.030 |
Why?
|
| Quercus | 1 | 2015 | 31 | 0.030 |
Why?
|
| Family | 1 | 1996 | 332 | 0.030 |
Why?
|
| Video Recording | 1 | 2014 | 214 | 0.020 |
Why?
|
| Quality of Life | 1 | 2021 | 1816 | 0.020 |
Why?
|
| Analgesics, Opioid | 1 | 2016 | 513 | 0.020 |
Why?
|
| Substance-Related Disorders | 1 | 1996 | 451 | 0.020 |
Why?
|
| Cell Differentiation | 2 | 2008 | 1666 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 1996 | 1981 | 0.020 |
Why?
|
| Neuroacanthocytosis | 1 | 2007 | 2 | 0.020 |
Why?
|
| Amino Acid Transport Systems, Neutral | 1 | 2007 | 5 | 0.020 |
Why?
|
| Blood Group Antigens | 1 | 2007 | 16 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 2007 | 81 | 0.020 |
Why?
|
| Bone Morphogenetic Protein 6 | 1 | 2007 | 10 | 0.020 |
Why?
|
| Bone Morphogenetic Protein 3 | 1 | 2007 | 6 | 0.020 |
Why?
|
| Bone Morphogenetic Protein 7 | 1 | 2007 | 13 | 0.020 |
Why?
|
| Helix-Loop-Helix Motifs | 1 | 2007 | 27 | 0.020 |
Why?
|
| Injections, Intramuscular | 1 | 2007 | 66 | 0.020 |
Why?
|
| Ossification, Heterotopic | 1 | 2007 | 32 | 0.020 |
Why?
|
| Growth Differentiation Factors | 1 | 2007 | 58 | 0.020 |
Why?
|
| Syndrome | 1 | 2007 | 453 | 0.020 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2007 | 62 | 0.020 |
Why?
|
| Mice, Inbred C3H | 1 | 2007 | 372 | 0.020 |
Why?
|
| Adipocytes | 1 | 2008 | 172 | 0.020 |
Why?
|
| Signal Transduction | 2 | 2008 | 3586 | 0.020 |
Why?
|
| Growth Differentiation Factor 2 | 1 | 2007 | 158 | 0.020 |
Why?
|
| Cell Lineage | 1 | 2008 | 324 | 0.020 |
Why?
|
| Hydromorphone | 1 | 2005 | 11 | 0.020 |
Why?
|
| Infusion Pumps | 1 | 2005 | 27 | 0.010 |
Why?
|
| Narcotics | 1 | 2005 | 72 | 0.010 |
Why?
|
| Mice, Nude | 1 | 2007 | 842 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2007 | 1034 | 0.010 |
Why?
|
| Transforming Growth Factor beta | 1 | 2007 | 349 | 0.010 |
Why?
|
| Child | 1 | 1996 | 7626 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2008 | 1192 | 0.010 |
Why?
|
| Lumbar Vertebrae | 1 | 2005 | 363 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2007 | 2943 | 0.010 |
Why?
|
| Kidney | 1 | 2007 | 1156 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2007 | 1534 | 0.010 |
Why?
|
| Phenotype | 1 | 2007 | 2579 | 0.010 |
Why?
|
| Biomarkers | 1 | 2007 | 1933 | 0.010 |
Why?
|
| Mice | 1 | 2007 | 12562 | 0.010 |
Why?
|